Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the aryl hydrocarbon receptor market grown over the years?

The market for aryl hydrocarbon receptors has witnessed robust growth in the past few years. The market, valued at $4.64 billion in 2024, is projected to expand to $5.01 billion in 2025, translating to a compound annual growth rate (CAGR) of 8.1%. Factors that have propelled historical growth include heightened awareness about environmental toxins, increased oncology research, a surge in autoimmune disease studies, a rising fascination with targeted therapies, and the broadening scope of applications in drug development.

What Is the forecasted market size and growth rate for the aryl hydrocarbon receptor market?

In the following years, it is anticipated that the aryl hydrocarbon receptor market will experience robust growth, ascending to a value of $6.79 billion in 2029 with an annual compound growth rate of 7.9%. The increase during the predictive period is likely to be driven by factors such as increased investment in precision medicine, a surge in demand for immunotherapy, heightened focus on environmental health, growth in applications for inflammatory diseases, and ongoing advancements in drug identification. The forecast period will also witness prominent trends such as progress in targeted cancer therapies, the application of precision medicine strategies, advancements in toxicology research, the use of AI in drug exploration, and development in the treatment of autoimmune diseases.

Get your aryl hydrocarbon receptor market report here!

https://www.thebusinessresearchcompany.com/report/aryl-hydrocarbon-receptor-global-market-report

What are the major factors driving growth in the aryl hydrocarbon receptor market?

An upward trend in autoimmune diseases and chronic conditions is predicted to fuel the expansion of the aryl hydrocarbon receptor market. These diseases and conditions are lifelong ailments in which the immune system doesn’t function properly or health problems continue. The escalation in these types of diseases and conditions is attributed to genetic factors, environmental influences, lifestyle, gut imbalances, and improved diagnostic skills. Agonists for the aryl hydrocarbon receptor (AHR) have the ability to regulate immune responses and inflammation, thus offering potential treatment benefits for autoimmune diseases and chronic conditions by controlling T-cell differentiation and immune cell operation. For example, Public Health Scotland data from July 2023 highlighted that the proportion of newly diagnosed patients with multiple sclerosis (MS) in 2022 rose to 87.2%, an increase from 85.7%, with 491 novel cases reported, culminating in a total of 6,359 cases in 2022. Consequently, the growth in autoimmune diseases and chronic conditions is stimulating the market for aryl hydrocarbon receptor (AHR) agonists.

What key areas define the segmentation of the global aryl hydrocarbon receptor Market?

The aryl hydrocarbon receptor market covered in this report is segmented –

1) By Type: CB-993113, CDR-914K058, Cinnabarinic Acid, Other Types

2) By Distribution Channel: Direct Sales, Online Platforms, Distributors, Retail Pharmacies, Wholesale Suppliers

3) By Application: Hepatocellular Carcinoma, Multiple Sclerosis, Obesity, Osteoporosis, Other Applications

4) By End-User Industry: Pharmaceuticals, Biotechnology, Agriculture, Environmental Consultancy, Research Institutions

Subsegments:

1) By CB-993113: Preclinical Stage CB-993113, Clinical Trials of CB-993113, Targeted Applications of CB-993113

2) By CDR-914K058: Preclinical Development of CDR-914K058, CDR-914K058 in Immunological Disorders, Targeted Therapeutic Areas for CDR-914K058

3) By Cinnabarinic Acid: Mechanism Of Action Of Cinnabarinic Acid, Cinnabarinic Acid In Inflammatory Conditions, Potential Applications In Neurodegenerative Diseases

4) By Other Types: Synthetic Aryl Hydrocarbon Receptor Agonists, Natural Aryl Hydrocarbon Receptor Ligands, Novel Aryl Hydrocarbon Receptor Modulators

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21106&type=smp

What are the top market players propelling the growth of the aryl hydrocarbon receptor industry?

Major companies operating in the aryl hydrocarbon receptor market are Bayer AG, Eli Lilly and Company, Organon & Co., Sigma-Aldrich Corporation, Bio-Techne Corporation, Abcam plc, R&D Systems Inc., Dermavant Sciences Inc., Cayman Chemical Company, Enzo Life Sciences Inc., Tocris Bioscience, Ikena Oncology Inc., MedChemExpress LLC, Hercules Pharmaceuticals BV, Active Biotech AB, AnTolRx Inc., Aqilion AB, Azora Therapeutics Australia Pty Ltd, Sol-Gel Technologies Ltd., Actavalon Inc.

What are the key trends shaping the future of the aryl hydrocarbon receptor market?

Key players in the aryl hydrocarbon receptor market are concentrating on the innovation of superior products such as topical medication, which is devised to target specific inflammatory routes. These products offer potential therapies for autoimmune disorders like psoriasis, multiple sclerosis, and various other chronic inflammation-related conditions, with reduced systemic side effects. Topical medications are drugs applied directly to the skin or mucous membranes to manage localized symptoms or conditions. For example, Dermavant Sciences, a biopharmaceutical company based in the U.S., in May 2022, received approval from the U.S. Food and Drug Administration (FDA) for VTAMA (tapinarof) cream, 1%. This unique non-steroidal treatment provides a new mode of action via selective aryl hydrocarbon receptor modulation. This daily-apply cream provides an easy-to-use treatment option for patients. Moreover, it has proven to have a satisfactory safety profile with limited systemic absorption, thereby setting it apart from conventional therapies.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21106

What regions are dominating the aryl hydrocarbon receptor market growth?

North America was the largest region in the aryl hydrocarbon receptor market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aryl hydrocarbon receptor market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Hepatitis B Virus (HBV) Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hepatitis-b-virus-hbv-global-market-report

Rotavirus Prophylaxis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rotavirus-prophylaxis-global-market-report

Multidrug Resistant Bacteria Global Market Report 2025

https://thebusinessresearchcompany.com/report/multidrug-resistant-bacteria-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: